Researchers at Stanford University have grown human brain organoids inside mice that lack a neocortex and hippocampus, a technique called xenocortication. Published in Nature, the approach allows human neural tissue to expand up to 4.7-fold in three months, forming complex networks and responding to host physiology.
Scientists have pushed the boundaries of neuroscience by cultivating human brain tissue inside living rodents. Stanford University researchers developed a method called xenocortication, enabling human neural organoids to claim empty space inside a modified mouse brain and develop into complex functional circuits.
Overcoming Size Barriers Through Xenocortication
For years, researchers worked to integrate lab-grown human brain organoids into animal nervous systems. Those earlier attempts hit a major biological roadblock. Human brain tissue grows roughly 20 times slower than mouse tissue, causing fast-maturing host brains to crowd out and restrict the foreign organoids.
To solve this spatial dilemma, the research team engineered mice to lack much of their neocortex and hippocampus by deleting the sister chromatid cohesion gene known as Esco2 on an immunocompromised SCID background. These immunodeficient, cortex-depleted animals provided a vacant biological landscape. Over his short career, 44-year-old Sergiu Pașca, MD, has changed how scientists study the developing human nervous system.
When the team transplanted human cortical organoids into these newborn hosts, the tissue thrived. Graft volume expanded 4.7-fold within two to three months, with human-derived tissue eventually accounting for 91.9% of the cortical tissue volume, according to Inside Precision Medicine.
Structural Integration and Functional Connections
The resulting tissue mimics complex brain functioning by establishing viable neural networks. Although the tissue remains short of a fully formed human cortex, it contains a large diversity of cortical cell types, including astrocytes.
The structural integration runs both ways. Human neurons project organized axonal tracts toward the superior colliculus, while mouse neurons from the thalamus, pallidum, and paleocortex project back into the human graft. Human-derived projections even reached the cervical spinal cord, a structural milestone not observed when organoids are placed into mice with intact brains.
Sergiu Pașca, Stanford University researcher, stated that it is still not a fully formed human cortex, but it contains a large diversity of cortical cell types, including astrocytes.
Modeling Disease and Responding to Injury
This level of integration gives researchers a living platform to study neuropsychiatric disorders and specific neural injuries in ways petri dishes cannot match. The model allows scientists to investigate human cells and circuits embedded inside a functioning mammalian nervous system. In a new Nature study, Pașca and his colleagues describe xenocortication, an approach in which human cortical organoids are transplanted into mice genetically engineered so that most of the neocortex and hippocampus never form.
To test the model’s utility, the team induced hypoxic injury in the host mice. The response demonstrated deep functional integration.
Sergiu Pașca, Stanford University, explained that when they induce hypoxia in the xenocortical mice, the microglia from the mouse react to hypoxia, noting that they are not reacting to a hypoxic injury of the mouse cortex because there is essentially no mouse cortex there, but rather reacting to the injury of human cells.
The researchers emphasize that xenocortication serves as a complementary instrument rather than an all-encompassing replacement for existing laboratory models. Pașca told Inside Precision Medicine that this is not an all-in-one, universal system that is here to replace previous models, but rather to complement them.
Ethical Oversight and Governance
The creation of rodents carrying large volumes of human brain tissue raises inevitable ethical questions regarding animal welfare, pain perception, and rudimentary consciousness. The research team anticipated these concerns and established strict oversight frameworks during the course of the work.
Stanford University formed an external ethics committee comprising ethicists, legal scholars, patient advocates, and neuroscientists to monitor the experiments. Researchers presented updates regularly to the committee to track both animal welfare and any unanticipated behavioral changes.
Sergiu Pașca, director of the Stanford Brain Organogenesis Program, noted that they have taken extraordinary measures in terms of ethical oversight over the past few years.
Продолжение темы
